<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE root>
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" article-type="research-article" dtd-version="1.2" xml:lang="en"><front><journal-meta><journal-id journal-id-type="publisher-id">Russian Journal of Allergy</journal-id><journal-title-group><journal-title xml:lang="en">Russian Journal of Allergy</journal-title><trans-title-group xml:lang="ru"><trans-title>Российский Аллергологический Журнал</trans-title></trans-title-group></journal-title-group><issn publication-format="print">1810-8830</issn><issn publication-format="electronic">2686-682X</issn><publisher><publisher-name xml:lang="en">Publishing House ABV Press</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">1288</article-id><article-categories><subj-group subj-group-type="toc-heading" xml:lang="en"><subject>Articles</subject></subj-group><subj-group subj-group-type="toc-heading" xml:lang="ru"><subject>Статьи</subject></subj-group><subj-group subj-group-type="article-type"><subject>Research Article</subject></subj-group></article-categories><title-group><article-title xml:lang="en">Dynamic stabilometry and immunological patterns of chronic fatigue syndrome in patients with various types of multiple sclerosis</article-title><trans-title-group xml:lang="ru"><trans-title>Динамическая стабилометрия и иммунологические паттерны синдрома хронической усталости у больных с различным типом течения рассеянного склероза</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Shagaev</surname><given-names>A S</given-names></name><name xml:lang="ru"><surname>Шагаев</surname><given-names>А С</given-names></name></name-alternatives><bio xml:lang="en"><p>Department of Neurology and Neurosurgery</p></bio><bio xml:lang="ru"><p>Кафедра неврологии и нейрохирургии</p></bio><email>info@rusalljournal.ru</email><xref ref-type="aff" rid="aff1"/><xref ref-type="aff" rid="aff2"/><xref ref-type="aff" rid="aff3"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Boyko</surname><given-names>A N</given-names></name><name xml:lang="ru"><surname>Бойко</surname><given-names>А Н</given-names></name></name-alternatives><bio xml:lang="en"><p>Department of Neurology and Neurosurgery</p></bio><bio xml:lang="ru"><p>Кафедра неврологии и нейрохирургии</p></bio><email>info@rusalljournal.ru</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Bakharev</surname><given-names>B V</given-names></name><name xml:lang="ru"><surname>Бахарев</surname><given-names>Б В</given-names></name></name-alternatives><email>info@rusalljournal.ru</email><xref ref-type="aff" rid="aff2"/></contrib></contrib-group><aff-alternatives id="aff1"><aff><institution xml:lang="en">Russian State Medical Universite</institution></aff><aff><institution xml:lang="ru">Российский государственный медицинский университет</institution></aff></aff-alternatives><aff-alternatives id="aff2"><aff><institution xml:lang="en">Institute of Cell Biophysics RAS</institution></aff><aff><institution xml:lang="ru">Институт биофизики клетки РАН</institution></aff></aff-alternatives><aff-alternatives id="aff3"><aff><institution xml:lang="en">Russian Academy of Sciences, Hospital №1 in Pushchino</institution></aff><aff><institution xml:lang="ru">РАН., Больница №1 г.Пущино</institution></aff></aff-alternatives><pub-date date-type="pub" iso-8601-date="2019-12-15" publication-format="electronic"><day>15</day><month>12</month><year>2019</year></pub-date><volume>16</volume><issue>1S</issue><issue-title xml:lang="en">VOL 16, NOS1 (2019)</issue-title><issue-title xml:lang="ru">ТОМ 16, №S1 (2019)</issue-title><fpage>168</fpage><lpage>172</lpage><history><date date-type="received" iso-8601-date="2020-04-02"><day>02</day><month>04</month><year>2020</year></date></history><permissions><copyright-statement xml:lang="en">Copyright ©; 2019, Pharmarus Print Media</copyright-statement><copyright-statement xml:lang="ru">Copyright ©; 2019, Фармарус Принт Медиа</copyright-statement><copyright-year>2019</copyright-year><copyright-holder xml:lang="en">Pharmarus Print Media</copyright-holder><copyright-holder xml:lang="ru">Фармарус Принт Медиа</copyright-holder><ali:free_to_read xmlns:ali="http://www.niso.org/schemas/ali/1.0/" start_date="2021-11-01"/></permissions><self-uri xlink:href="https://rusalljournal.ru/raj/article/view/1288">https://rusalljournal.ru/raj/article/view/1288</self-uri><abstract xml:lang="en"><p>Chronic fatigue (XY), along with motor and coordination disorders, is one of the most common syndromes in multiple sclerosis (MS). In spite of certain successes in the pathogenetic treatment of MS, the correction of the chronic fatigue syndrome (CFS) remains completely unresolved. This report presents preliminary positive experience on the use of integrated reabilitation using the biofeedback method (BFB). The effectiveness of this method for the treatment of patients with MS is shown. Recommendations are made about the possibility of using this method in patients with MS with varying severity of neurological deficit</p></abstract><trans-abstract xml:lang="ru"><p>Хроническая усталость (ХУ) наряду с двигательными и координаторными нарушениями, является, одним из наиболее часто встречающихся синдромом при рассеянном склерозе (РС). Несмотря на определенные успехи в патогенетическом лечении РС коррекция синдрома хронической усталости (СХУ) остается полностью не решенной. В данном сообщении представлен предварительный позитивный опыт по использованию комплексной реабилитации по методу биологической обратной связи (БОС). Показана эффективность этого метода для лечения больных РС. Сформулированы рекомендации о возможности применения этого метода у больных РС с различной степенью тяжести неврологического дефицита.</p></trans-abstract><kwd-group xml:lang="en"><kwd>multiple sclerosis</kwd><kwd>chronic fatigue stabilometric analysis</kwd><kwd>biological feedback</kwd><kwd>“center of pressure”</kwd><kwd>symptomatic treatment</kwd><kwd>cytokines</kwd><kwd>moderate exercise</kwd><kwd>training</kwd><kwd>rehabilitation</kwd></kwd-group><kwd-group xml:lang="ru"><kwd>рассеянный склероз</kwd><kwd>хроническая усталость</kwd><kwd>стабилометрический анализ</kwd><kwd>биологическая обратная связь</kwd><kwd>«центр давления»</kwd><kwd>симптоматическое лечение</kwd><kwd>цитокины</kwd><kwd>умеренная физическая нагрузка</kwd><kwd>тренинги</kwd><kwd>реабилитация</kwd></kwd-group><funding-group/></article-meta></front><body></body><back><ref-list><ref id="B1"><label>1.</label><mixed-citation>Алексеева Т.Г., Бойко А.Н., Гусев Е.И. Спектр нейропсихологических изменений при рассеянном склерозе. Ж.Невр.и псих., Спец.выпуск «Рассеянный склероз».2000;11:15-20.</mixed-citation></ref><ref id="B2"><label>2.</label><mixed-citation>Алексеева Т.Г., Еникополова Е.В., Садальский Е.В., и др.Комплексный подход к оценке когнитивной и эмоционально-личностной сфер у больных рассенным склерозом. Ж.Невр и псих, Спец. выпуск «Рассеянный склероз».2002;1:20-26.</mixed-citation></ref><ref id="B3"><label>3.</label><mixed-citation>Батышева Т. Т. Система медицинской реабилитации двигательных нарушений у неврологических больных в амбулаторных условиях: Автореф. дисс. на соискание уч.степени д.м.н.-Москва., 2005.-64с.</mixed-citation></ref><ref id="B4"><label>4.</label><mixed-citation>Батышева. Т. Т. Система медицинской реабилитации двигательных нарушений у неврологических больных в амбулаторных условиях: Автореф.дисс. на соискание уч.степени д.м.н.-Москва., 2005.-5с.</mixed-citation></ref><ref id="B5"><label>5.</label><mixed-citation>Бахарев Б.В. Статистическая обработка данных. Критерии проверки данных. Пакет программ «статистика», материалы по математическому обеспечению ЭВМ. Сб.трудов,-г.Пущино.,-1989.- выпуск 15,- 34 с.</mixed-citation></ref><ref id="B6"><label>6.</label><mixed-citation>Гехт Б.М., Меркулова Д.М., Касаткина Л.Ф., Самойлов М.И. Клиника, диагностика и лечение демиелинизирующих полиневропатий. Невр. Журн.1996;1:12-17.</mixed-citation></ref><ref id="B7"><label>7.</label><mixed-citation>Гусев Е.И., Бойко А.Н.,Завалишин И.А.Эпидемиологические исследования рассеянного склероза. Методические рекомендации.-Москва.- 2003. -№ 2003/82:4-32.</mixed-citation></ref><ref id="B8"><label>8.</label><mixed-citation>Гусев Е.И.,Бойко А.Н., Завалишин. И.А.Рассеянный склероз и другие демиелинизирующие заболевания: рук. для врачей - М.: «Миклош», 2004. -8с</mixed-citation></ref><ref id="B9"><label>9.</label><mixed-citation>Демина М.Л., Попова Н.Ф. Симптоматическая терапия рассеянного склероза. J. ConsiliumMedicum. 2002.,т.4; 2: 6-9</mixed-citation></ref><ref id="B10"><label>10.</label><mixed-citation>Шмидт Т.Е.,Елагина И.А., Яхно Н.Н. Синдром утомляемости при различных типах течения рассеянного склероза. Невр.Журн.2012; 3:12-19.</mixed-citation></ref><ref id="B11"><label>11.</label><mixed-citation>Amato M.P ,Portaccio E. Management option in multiple sclerosis-assotiated fatigue. Expert OpinPharmacother. 2012; 13:207-216: doi:10.1517/14656566.2012.647767. [Pub Med].</mixed-citation></ref><ref id="B12"><label>12.</label><mixed-citation>Berlestmann F.W., Polman C.H., van Diemann HAM., et all, A comparison between 4-aminopyridine and 3,4-di-aminopyridine in the treatment of multiple sclerosis. Ann Neurol 1992, 32:256.</mixed-citation></ref><ref id="B13"><label>13.</label><mixed-citation>Bever C.T., Panitch H.S., Anderson P.A., et al. The effects of 4-aminopyridine in multiple sclerosis patients : results of randomized, placebo-controled, double-blind , consentration-controlled, crossover trial. Neurology 1994, 44: 1054-1059.</mixed-citation></ref><ref id="B14"><label>14.</label><mixed-citation>Carro E,Nunez A, Busiguina S, Torres-Aleman I. Circulating insulin like growth factor I mediates effect of exercise on the brain. J, Neurosci. 2000; 20(8): 2926-2933.</mixed-citation></ref><ref id="B15"><label>15.</label><mixed-citation>Carro E, Trijo JL, Busiguina S, Torres-Aleman I. Circulating insulin like growth factor I mediates the protective effects of physical exercise against brain insults of different etiology and anatomy. J.Neurosci. 2001; 21(15): 5678-5684.</mixed-citation></ref><ref id="B16"><label>16.</label><mixed-citation>Сastellano V., Patel D.I, White L I. Cytokine responses to acute and chronic exercise in multiple sclerosis. J. ApplPhisiol. 2008; 104:1697-1702. Doi: 10.1152/ japplphysiol.00954.2007[Pab. Med]</mixed-citation></ref><ref id="B17"><label>17.</label><mixed-citation>Castellano, V. Patel, DI, White, LJ. Cytokine responses and PGC1 in inflammation and chronic disease. Nature. 2008; 454 (24); 463-469.</mixed-citation></ref><ref id="B18"><label>18.</label><mixed-citation>Flacheneker P, Bihler I. Cytocine mRNA ex-pression in patients with MS and fatigue.Mult.Scler. 2004; 10.165-169. Doi: 10.1191/1352458504ms 991oa. [Pab. Med].</mixed-citation></ref><ref id="B19"><label>19.</label><mixed-citation>Gold SM, Kruger S, Ziegler KJ, Krieger T, Schulz KH, Otte C, Heesen C. Endocrine and Immune substrates of depressive symptoms and fatigue in multiple sclerosis patients with comorbid major depres-sion. J. Neurol-NeurosurgPsychiatr. 2011; 82:814-818. Doi: 10.1136/ jnnp.2010.2300.29.[Pub Med ].</mixed-citation></ref><ref id="B20"><label>20.</label><mixed-citation>Golzari, Z, Shadkhis, F, Soudi, S, Kordi, MR, Hasmeri , SM. Combined exercise training redices IFN.-gamma and. IL-17 levels plasma and the suripheral blood mononuclear cells in women with multiple sclerosis. International Immunopharmacology. 2010; 10:1415-1419.</mixed-citation></ref><ref id="B21"><label>21.</label><mixed-citation>Gottschalk M. Kumpfel T, Flachenecker P, Uhr M, Trenkwalder C, Holsboer F, Weber F. Fatigue and regulation of the hypothalamo-pituitary-adrenal axis in multiple sclerosis. Arch Neurol. 2005 ; 62:277-280. Doi. 10.1001/archneur.62.2.277.[Pab. Med]</mixed-citation></ref><ref id="B22"><label>22.</label><mixed-citation>Hessen C, Nawrath L, Reich N, Schulz KH, Gold SM. Fatigue in multiple sclerosis: an example of cytokine mediated sickness behaviour. J. NeurolNeurosurgPsychitr. 2006; 77:34-39. Doi: 10.1136/jnnp. 2005.065805. [Pab Med].</mixed-citation></ref><ref id="B23"><label>23.</label><mixed-citation>Hessen, C, Gold. SM, Hartmann, S, Mladek.,,,M, Reer, R, Braumann, KM, Wiedemann. K, Schulrz, KH. Endocrine and cytokine responses to standardized physical stress in multiple sclerosis. Brain. Behavior and Immunity. 2003; 17:473-481.</mixed-citation></ref><ref id="B24"><label>24.</label><mixed-citation>Kurtzke J.F. Rating neurological impairment in multiple sclerosis and expanded disability status scale (EDSS), Neurology 1983; 33, 1444-52.</mixed-citation></ref><ref id="B25"><label>25.</label><mixed-citation>McDonald WI, Compston A, Edan G, et al. Recommended diagnostic criteria for multiple sclerosis: guidelines from the International Panel on the diagnosis of multiple sclerosis. Ann Neurol 2001;50:121-127</mixed-citation></ref><ref id="B26"><label>26.</label><mixed-citation>Schulz KN, Gold SM, Witte et al. Impact of aerobic training on immune-endocrine parameters, neurotrophic factors, quality of life and coordinative function in multiple sclerosis. J. Neurol Sci. 2004; 225(1-2): 11-18)</mixed-citation></ref><ref id="B27"><label>27.</label><mixed-citation>The multiple sclerosis quality of life inventory: A User s Manual. National Multiple Sclerosis., 1999; p.3.</mixed-citation></ref><ref id="B28"><label>28.</label><mixed-citation>White, LJ, Castellano, V. McCoy. SC. Cytokine responses to resistansetraning in people with multiple sclerosis. Journal of Sports Scienes. 2006; 24(8): 911-914.</mixed-citation></ref><ref id="B29"><label>29.</label><mixed-citation>Zwarts MJ, Bleijenberg G, van Engelen BG. « Qinical neurophysiology of fatigue», Qinical neurophysiology, vol.119.no. I.pp.2-10. 2008. View at Publisher.</mixed-citation></ref></ref-list></back></article>
